Melanie P. Matheu

University of California San Francisco Diabetes Center

University of California, San Francisco

Melanie P. Matheu

Dr. Melanie Matheu is the founder of Prellis Biologics. Dr. Matheu studied immunology for 15 years and authored numerous peer-reviewed publications and a book chapter detailing methods and approaches for high-resolution imaging in tissues before starting Prellis Biologics in October 2016. She was inspired to find a way to reverse-engineer laser-based imaging systems into a printer when she realized that the final roadblock in engineering human tissue and organs for transplant was a simple and well-defined engineering problem: how can microvasculature be printed fast enough to build human tissues? Prellis Biologics' technology solves this problem by partially decoupling printing speed from resolution with a novel patent-pending laser based projection system.



1Molecular Biology and Biochemistry, University of California, Irvine, 2Physiology and Biophysics, University of California, Irvine, 3Neurobiology and Behavior, University of California, Irvine, 4University of California San Francisco Diabetes Center, University of California, San Francisco, 5Pathology, University of Utah

JoVE 52580